Robby A. Petros

4.7k citations
21 papers · 3.9k indexed · 1 hit paper · h-index 12
Topics
Nanoparticle-Based Drug Delivery (7 papers)Chemical Synthesis and Analysis (3 papers)Plant Parasitism and Resistance (3 papers)
Partner nations
United States

In The Last Decade

Robby A. Petros

20 papers receiving 3.8k citations

Hit Papers

Strategies in the design of nanoparticles for therapeutic...2010202620152020201050010001.5k2.0k2.5k

Peers

Robby A. Petros
Comparison fields: 5 of 127
  • Biomaterials 1.9k
  • Molecular Biology 1.5k
  • Biomedical Engineering 1.5k
  • Materials Chemistry 664
  • Organic Chemistry 398
Replace Stephanie E. A. Gratton with:
Stephanie E. A. Gratton United States
Pedro M. Valencia United States
Benjamin A. Teply United States
Patricia A. Ropp United States
Min Xue China
Igor Chourpa France
Irène Brigger France
Patrick D. Pohlhaus United States
Miriam Colombo Italy
Xiao‐Jiao Du China
Robby A. Petros relative to Stephanie E. A. Gratton United States Stephanie E. A. Gratton's profile →
Citations per field
00.5×1.7×
Stephanie E. A. Gratton · 1×
Citations per year

Countries citing papers authored by Robby A. Petros

Since Specialization
Citations

This map shows the geographic impact of Robby A. Petros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robby A. Petros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robby A. Petros more than expected).

Fields of papers citing papers by Robby A. Petros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robby A. Petros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robby A. Petros. The network helps show where Robby A. Petros may publish in the future.

Co-authorship network of co-authors of Robby A. Petros

This figure shows the co-authorship network connecting the top 25 collaborators of Robby A. Petros. A scholar is included among the top collaborators of Robby A. Petros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robby A. Petros. Robby A. Petros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 2
3 0
4 19
5 13
6 11
7 9
8 6
9 109
10 4
11 5
12 175
13 6
14 65
15 3
16
Strategies in the design of nanoparticles for therapeutic applicationsbreakdown →
2976
17 272
18 22
19 115
20 12

About Robby A. Petros

Robby A. Petros is a scholar working on Biomaterials, Inorganic Chemistry and Bioengineering, having authored 21 papers that have together received 3.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Chemical Synthesis and Analysis (3 papers) and Plant Parasitism and Resistance (3 papers). The work is most often cited by research in Biomaterials (1.9k citations), Pharmaceutical Science (261 citations) and Biomedical Engineering (1.5k citations). Robby A. Petros has collaborated with scholars based in United States. Frequent co-authors include Joseph M. DeSimone, Mary E. Napier, Shaomin Tian, Jin Wang, Jack R. Norton, Jyoti Shah, Ratnesh Chaturvedi, Barney J. Venables, Patricia A. Ropp and James M. Camara. Their work appears in journals such as Journal of the American Chemical Society, Nature Reviews Drug Discovery and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026